Clinical Trial Update: To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia. [Phase 3]

View source ↗

Summary

This phase 3 clinical trial reports long-term safety and efficacy data for pregabalin in patients with postherpetic neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Lyrica (Pregabalin)

Snippet

Sponsor: Pfizer | Conditions: Neuralgia | Phase 3 | Status: COMPLETED